Clinical Study
Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy
Table 3
Univariate competing risk regression for the relationship between clinical characteristics of the patients and time to PSE.
| Items | PSE Present (n=38) | PSE Absent (n=82) | HR(95%CI) | P |
| Age (mean ± SD, years) | 55.3±8.31 | 51.9±8.97 | 0.634(0.218-1.402) | NS | CTP Stage A/B/C (n.) | 19/14/5 | 45/23/14 | 1.482(0.547-3.563) | NS | MELD score | 8.07±3.96 | 7.36±4.13 | 0.744(0.156-1.215) | NS | Ammonia (mean ± SD, μmol/L) | 51.6±16.7 | 99.4±20.9 | 1.997(1.163-3.563) | 0.027 | PPG reduction (mean ± SD, mmHg) | 11.3±1.51 | 10.1±2.63 | 1.133(0.896-1.427) | NS | Mitochondrial damage(Group A/B) | 19/19 | 23/59 | 2.561(1.615-3.873) | 0.017 |
|
|
HR: hazard ratio.
|